Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish study
about
High-Throughput GoMiner, an 'industrial-strength' integrative gene ontology tool for interpretation of multiple-microarray experiments, with application to studies of Common Variable Immune Deficiency (CVID).International Consensus Document (ICON): Common Variable Immunodeficiency DisordersCancers Related to Immunodeficiencies: Update and PerspectivesUpdate in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditionsRecognition, clinical diagnosis and management of patients with primary antibody deficiencies: a systematic reviewSelective IgA Deficiency: Epidemiology, Pathogenesis, Clinical Phenotype, Diagnosis, Prognosis and Management.Common variable immunodeficiency: etiological and treatment issues.Serum bactericidal antibody response 1 year after meningococcal polysaccharide vaccination of patients with common variable immunodeficiencyThe many faces of common variable immunodeficiency.Clinical and immunological features of 65 Iranian patients with common variable immunodeficiencyHow I treat common variable immune deficiency.Morbidity and mortality in common variable immune deficiency over 4 decadesPathogenesis, diagnosis, and management of primary antibody deficiencies and infections.Proteomic analysis of sera from common variable immunodeficiency patients undergoing replacement intravenous immunoglobulin therapy.An unsual case of persistent inguinal swelling - beware immunodeficiency.The Incidence and Prevalence of Common Variable Immunodeficiency Disease in Taiwan, A Population-Based Study.Salivary Immunoglobulin A Secretion Rate Is Negatively Associated with Cancer Mortality: The West of Scotland Twenty-07 Study.Human normal immunoglobulin in the treatment of primary immunodeficiency diseases.Lymphoid proliferations of indeterminate malignant potential arising in adults with common variable immunodeficiency disorders: unusual case studies and immunohistological review in the light of possible causative eventsSerum bactericidal antibody responses to meningococcal polysaccharide vaccination as a basis for clinical classification of common variable immunodeficiencyCommon variable immunodeficiency: an updateTreatment with rituximab and brentuximab vedotin in a patient of common variable immune deficiency-associated classic Hodgkin lymphomaMetachronous Diffuse Large B-Cell Lymphoma and Kaposi Sarcoma of the Right Eyelid and Lacrimal Gland in a Patient with Granulomatous Common Variable Immunodeficiency.Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromesCancer risk after ABO-incompatible living-donor kidney transplantationReview of gastric cancer risk factors in patients with common variable immunodeficiency disorders, resulting in a proposal for a surveillance programme.DNA repair: the link between primary immunodeficiency and cancer.Therapeutic management of primary immunodeficiency in older patients.Immunomodulation and lymphoma in humans.Clinical phenotype classification for selective immunoglobulin A deficiency.Autoimmune and Lymphoproliferative Complications of Common Variable Immunodeficiency.Cancer in primary immunodeficiency diseases: Cancer incidence in the United States Immune Deficiency Network Registry.Clinical and imaging considerations in primary immunodeficiency disorders: an update.Outcomes of splenectomy in patients with common variable immunodeficiency (CVID): a survey of 45 patients.Successful Hematopoietic Stem Cell Transplantation in a Patient with LPS-Responsive Beige-Like Anchor (LRBA) Gene Mutation.Clonal Lymphoproliferations in a Patient With Common Variable Immunodeficiency.A Patient with CTLA-4 Haploinsufficiency Presenting Gastric Cancer.Non-Hodgkin lymphoma in pediatric patients with common variable immunodeficiency.Somatic Hypermutation Defects in Common Variable Immune Deficiency.Long-term follow-up on affinity maturation and memory B-cell generation in patients with common variable immunodeficiency.
P2860
Q24815153-ACC0EEFF-3CEA-43C1-B8A3-C97B25B7E394Q26777304-061C99E2-A866-4A18-9A19-2F294843186FQ28074182-2820DB0C-DE1C-45FE-BAA3-BA8D44AE3DE5Q28240370-5DBB1CC7-BEA5-491C-A56A-6C47FD914DE2Q28755847-5A8FB1B8-0C01-4E0A-BA4B-A7C8C09429E5Q30244309-89D7B7B1-DB6E-48EE-A72D-A4B5E384BF95Q33621805-A48EDAA1-0273-40A1-BA9B-27D7D025147CQ33768741-729DD8A8-02C4-4A0A-891B-5D633C19D477Q33790739-F0591789-61BC-444F-B16A-64B0B6792D3BQ33910840-366D948E-EED5-4385-8D84-88BAC164CD17Q33997226-843DD942-6E97-4E2B-965C-396F1562ABF6Q34241472-1C1200E7-5C88-4089-AB61-1B4DCF239B9AQ34992090-0242EAF7-535E-4448-861B-A331C5EA1F06Q35234211-E0E20815-0D2A-43E0-84FE-B661F1C38709Q35582191-E076C270-65BD-4468-B205-809B1132A49DQ35804720-F5F4B0A1-1A78-42C2-9100-F80AEBAFFC6DQ35877124-72E859D6-1A54-4AEC-8507-FDAD25332A77Q35905557-6E088106-78CA-4574-840C-2D689820A640Q36190436-098FAD34-CF8A-448A-8F00-E3F287A0D672Q36539053-F9042A76-1704-4245-8036-D8113059079FQ36633106-CB7B0900-B603-4E2E-AF03-43CCCD105B49Q36671605-17CD3D86-BB5C-43CC-B6E3-18F3E2C717BEQ36938395-EDF03EA4-B92E-4DFB-8E21-DFBC3B6DF4C9Q37116935-DFC65374-29BC-4658-B48C-96BC894430A4Q37138338-FB85413E-1FFA-48A6-9D1F-84299A60A5D6Q37862357-1C0235E4-FF6E-40A0-B0C4-78BE8BC67684Q37974984-18B0305B-2E81-482D-A0DD-8582B22187BAQ38100723-2FAE30A8-CB2D-480F-A8B9-194675C1DB44Q38112841-E290BC0C-354F-4319-A93C-1EE383679FA6Q38573627-93A58BFC-A775-4AAB-8DDF-FA53434AB1DFQ38726509-D73776BF-47CB-4B43-9765-C61FAB09FEF7Q38729286-627F95FE-1A22-414A-8EC9-4E3CFD0907A0Q38961320-312CEB2D-D610-4771-93A6-04CEE433C4B2Q39453651-057D7115-31B1-4230-9914-F982C61B2783Q39793998-C938DC42-D1CB-4181-8875-3EF3165BFF3EQ40544713-0F7EFD42-58EF-4A88-B88A-CE7C12871685Q40879964-33201151-5608-43DC-83FD-3ED1FA3AC3BEQ41271383-5B6F268D-B141-49E1-BAC0-069DD71AADDEQ41990566-345CE162-93B9-4659-9C87-E3BFF339BC64Q42263981-C7DD28B1-B9E2-459F-822C-77C3D9A19E73
P2860
Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish study
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Cancer risk among patients wit ...... bined Danish and Swedish study
@ast
Cancer risk among patients wit ...... bined Danish and Swedish study
@en
Cancer risk among patients wit ...... bined Danish and Swedish study
@nl
type
label
Cancer risk among patients wit ...... bined Danish and Swedish study
@ast
Cancer risk among patients wit ...... bined Danish and Swedish study
@en
Cancer risk among patients wit ...... bined Danish and Swedish study
@nl
prefLabel
Cancer risk among patients wit ...... bined Danish and Swedish study
@ast
Cancer risk among patients wit ...... bined Danish and Swedish study
@en
Cancer risk among patients wit ...... bined Danish and Swedish study
@nl
P2093
P2860
P50
P3181
P1476
Cancer risk among patients wit ...... bined Danish and Swedish study
@en
P2093
C Heilmann
J Bjorkander
L Hammarstrom
V Andersen
P2860
P304
P3181
P356
10.1046/J.1365-2249.2002.02004.X
P407
P577
2002-12-01T00:00:00Z